Another neurotoxin is in the pipeline, but will this one fill an unmet need? Dr. Joel Cohen explains.
Available for prescribing starting January 2020
JAK inhibitors have shown efficacy across several conditions due to the number and role of cytokines in the pathogenesis of these conditions, one expert says.
Dr. Susan Weinkle offers tips to minimize discomfort, which plays a large role in the patient’s perception of outcome.
Dr. Scott Dinehart discusses two newer methods for attacking squamous cell carcinoma, which he says are critical to know.
Patients with rosacea appear to have a significant increase in the risk of breast cancer when compared to those without this skin condition, according to a new study.
Radiodermatitis affects approximately 95% of all patients who receive radiation therapy for cancer - many of who are women undergoing breast cancer treatment. A recent study has found that developing the condition has a significant and detrimental impact on breast cancer patients' overall quality-of-life.
Hilary Baldwin, M.D., discusses the nuances of adult female acne and its treatments in her presentation at the Fall Clinical Dermatology Conference in Las Vegas.
For many years, genetic expression profiling has helped physicians predict which patients are at the highest risk of having their melanoma metastasize. Now, this same approach could aid in treating squamous cell carcinoma of the skin.